Human immunodeficiency virus (HIV)-2 differs from HIV-1 in its relative lower transmissibility and pathogenicity. To understand the virologic basis of these differences, the nef gene from HIV-2 -seropositive persons was analyzed because of its importance for disease progression in the genetically related simian immunodeficiency virus (SIV MAC ). Proviral nef sequences from 60 HIV-2 -infected persons were amplified from peripheral blood lymphocytes, and nef open-reading frames were screened by a transcription and translation assay for the presence of full-length (32-to 36-kDa) or truncated (õ32 kDa) Nef proteins. Overall, 6 (10%) of 60 persons had truncated Nef proteins; of these, 5 were among the 36 asymptomatic subjects (13.9%) and only 1 was among the 24 symptomatic subjects (4.2%) (P Å.23). The results of this study document the presence of defective nef genes in HIV-2 infections with a prevalence higher than that previously seen in HIV-1 -infected cohorts of long-term nonprogressors or patients with AIDS.
Human immunodeficiency virus types 1 and 2 (HIV-1 and may be important for understanding the pathogenicity of HIV--2) are genetically and biologically related lentiviruses that are 2 and HIV-1, for the development of attenuated viral vaccines, capable of causing CD4 T cell depletion and AIDS in infected and for the design of chemotherapeutic compounds. persons [1, 2] . However, HIV-1 and HIV-2 differ in their epideOverall, HIV-1 and HIV-2 share a similar genetic organizamiology and natural history. For example, HIV-2 -infected pertion. However, some differences in the number and size of sons have longer periods of clinical latency (õ0.5%/year for their accessory genes have been described [4] . For example, HIV-2 vs. 3% -5%/year for HIV-1 in the same cohort) and HIV-1 is lacking a genetic equivalent of the HIV-2 vpx gene survive longer after the appearance of symptoms than do perand has a shorter nef open-reading frame (ORF), while HIVsons infected with HIV-1 [1, 2] . HIV-2 has lower perinatal (0 -2 is lacking a vpu gene. To improve our understanding of the 4%/birth for HIV-2 vs. 25% -35%/birth for HIV-1) and sexual biologic differences between HIV-1 and HIV-2, we chose to transmission rates (Ç3-fold reduced for HIV-2) than does HIVfocus on the nef gene of HIV-2 for two reasons. First, an intact 1. The lower transmissibility of HIV-2 may help to explain the nef has been shown to be required for disease progression and geographic confinement of HIV-2 infection to persons from maintenance of high virus loads in experimental infections with West Africa and their contacts [1, 2] . Also, HIV-2 -infected the simian immunodeficiency virus (SIV) in adult macaques persons have lower infectious virus levels than do HIV-1 - [5 -7] . Second, because of the close genetic relatedness of SIV infected persons, especially during the asymptomatic stage [3] .
to HIV-2, it is conceivable that the HIV-2 nef may have a The basis of the biologic differences between HIV-1 and HIVsimilar role in the pathogenicity of infection with HIV-2. 2 remains unknown and may be related to host or viral factors
In contrast to SIV, the role of nef in the pathogenicity of (or both). The identification of viral factors for these differences HIV-1 infection in vivo is not fully understood. Two separate studies have described evidence of extensive deletions in the TT analysis of multiple clones to determine the frequency of quasifrom 79 HIV-2-seropositive persons were collected in a crossspecies with truncated Nef proteins in each sample. PCR-amplified sectional manner and stored at 080ЊC. The study participants innef genes from 14 samples were cloned into the pT7blue plasmid cluded 58 persons from the Ivory Coast (designated IC), of whom vector, and positive recombinants were selected by colony PCR 38 were asymptomatic women followed in a perinatal transmission using the T7-tagged sense primer 2T7NEF (5-CTAATACGAstudy and 20 were tuberculosis patients; 11 asymptomatic and 3 CTCACTATAGGGATGGGKKCRASTGGWTCCAAGsymptomatic persons residing in Spain (S); and 2 asymptomatic AAG-3; K Å G or T, R Å G or A, S Å G or C, W Å A or T) and 5 symptomatic persons residing in Portugal (P After incubation of the reaction mixture at 30ЊC for 2 h, 5 mL of zoster) for patients from Spain and Portugal. Participants were the TT reaction was mixed with 20 mL of SDS sample buffer screened for HIV antibodies by HIV-1/HIV-2 mixed ELISA (Genand boiled for 3 min to denature the proteins. Ten microliters of elavia Mixt; Diagnostics Pasteur, Paris), and the viral type was denatured protein and 15 mL of heat-denatured 14 C-labeled protein determined by a synthetic peptide-based test (Pepti-LAV; Diagstandards were electrophoresed in a 12% SDS-polyacrylamide gel, nostics Pasteur) and virus-specific Western blot (DuPont, Geneva, and the radiolabeled proteins were detected by fluorography after for HIV-1, and Diagnostics Pasteur for HIV-2). All samples were overnight exposure at 080ЊC [18] . reactive only in the HIV-2-specific serologic tests.
The second TT protocol for ORF examination involved screen-
Amplification of HIV-2 nef and long terminal repeat (LTR) se-
ing for Nef truncation by direct TT analysis of uncloned nef PCR quences. Cryopreserved PBMC were lysed at a concentration of products from a subset of samples (n Å 46). Primers 2T7NEF and 4-6 1 10 6 /mL in polymerase chain reaction (PCR) lysis buffer 2LTRRA were used in a third round of PCR to amplify proviral supplemented with 60 mg of proteinase K/mL at 56ЊC for 1 h.
nef sequences from 2 mL of the nested PCR reactions amplified Proteinase K was inactivated by boiling for 15 min, and the lysates from PBMC. These reactions generate T7-tagged nef sequences were stored at 020ЊC. Twenty-five microliters of lysate was used that serve as templates in the TT reaction. PCR templates that in first-round amplification of the nef sequence, with parameters expressed only truncated Nef proteins, or a mixture of truncated of 1 min for template denaturation at 94ЊC, 1 min of primer annealand full-length proteins, were selected and reanalyzed by the first ing at 45ЊC, and 1 min of primer extension at 72ЊC for 40 cycles TT protocol to quantitate the frequency of clones with truncated of PCR. The consensus oligomers 2NEFFD proteins. The second TT protocol allows a more rapid determina-GCCWGTWTTCTCYTCCCC-3; W Å T or A, Y Å T or C) tion of nef ORF status directly from PBMC by obviating the need and SLTR5 (5-ACCTGCTAGTGCTGGAGAGAACCT-3) were for cloning and screening of bacterial recombinants for full-length used to amplify a 1299-bp sequence encompassing the nef gene. or truncated nef sequences. As described in Results, this TT proceFive microliters of the first-round amplification product was used dure was validated on samples from the current study with known in a nested, 40-cycle PCR assay to amplify a 1125-bp sequence nef clones and was found to be a reliable and accurate alternative by using the consensus internal oligomers 2NEFFB to TT analysis of cloned nef sequences. AGCTGATTCGCCTCTTGA-3) and 2LTRRA (5-AACCTCSequence analysis of HIV-2 nef genes. nef genes that expressed CCAGGGCTCAATCTGCCAG-3). To confirm the specificity of truncated proteins by TT analysis were sequenced to determine the PCR reaction, the amplified products were Southern blotthe mechanism of truncation. The nef genes were cloned into the hybridized to the 32 P-labeled HIV-2 oligoprobe 2NEFP5 (5-GAApT7blue vector as described earlier. Plasmid DNA obtained by ATCGCCCTCCTGTGAGGGAC-3). Negative controls included using the Qiagen midi-prep system (Qiagen, Studio City, CA) reactions using uninfected PBMC lysates and water. Nested PCR was sequenced in both directions following the manufacturer's of the LTR was also done to confirm the positive HIV-2 serologic recommendations (Sequenase; United States Biochemical, Cleveresults by using the LTRA, LTRB, LTRC, and LTRD primers and land) [18] . The FASTA, MAP, PILEUP, and BESTFIT programs PCR conditions that were previously shown to be very sensitive in the Wisconsin Genetics Computer Group software package on and specific for the detection of HIV-2 sequences [17] .
a UNIX computer system were used for sequence analysis.
Analysis of HIV-2 nef ORFs. To rapidly analyze the nef gene
Nucleotide sequence accession numbers. The GenBank accesfor ORF interruptions, a coupled transcription and translation (TT) sion numbers of the seven HIV-2 nef genes sequenced in this study are U76639-U76643 and U76645. assay was done to determine the size of the Nef protein that is / 9D3D$$JA25
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Results
Seven persons had samples that showed a mixture of full-length and truncated proteins with varying proportions. Of these, 5 Amplification of HIV-2 LTR and nef sequences. Of the 79 samples (IC763001, IC763000, IC763023, S139, S173) had a samples studied, 74 (94%) were positive for the LTR region majority of clones expressing full-length Nef proteins, with and 60 (76%) were PCR-positive for nef sequences. Of the truncated Nef proteins present in only 5% -29% of the clones 19 samples negative for nef sequences, 15 (79%) were from examined from these samples. These 5 samples were considasymptomatic persons and 4 (21%) were from symptomatic ered to have full-length nef genes. In contrast, 2 samples persons. Of the 5 persons with negative LTR PCR results, 4 (IC763006 and IC763115) were clearly different and had a were asymptomatic and 1 was symptomatic. The negative nef higher proportion of clones with truncated Nef proteins (62% and LTR PCR results were seen despite the use of nested PCR and 81%, respectively). Therefore, these samples were considwith consensus primers, suggesting that the negative results ered to have the majority of nef clones with truncated Nef may be due to extremely low provirus loads or sequence variaproteins. tion at the primer sites (or both).
The use of TT analysis on uncloned nef sequences allowed Analysis of HIV-2 nef ORFs. Nef TT results for the asympa direct and rapid determination of the major nef quasispecies tomatic and symptomatic patient groups are summarized in from the HIV-2 -infected PBMC. This modified procedure was table 1. Overall, samples from 6 persons were identified in which all, or the majority of, Nef clones were truncated (6/60, fied by using the TT protocol with cloned nef sequences and S1084 7 0 7 (100, 28) 3 were identified by using the direct TT analysis of the uncloned IC763115 16 3 (19, 34) 13 (81, õ14) IC763006 13 5 (39, 34) 8 (61, 24) nef PCR products. The size of the full-length Nef proteins IC763001 11 10 (91, 34) 1 (9, õ14) was found to range predominantly between Ç32 and 34 kDa, IC763017 9 9 (100, 36) 0 although a few clones generated Nef proteins of Ç36 kDa. In IC763027 3 3 (100, 34) 0 contrast, the sizes of the truncated (or faster-migrating) Nef IC763000 21 20 (95, [32] [33] [34] 1 (5, õ14) proteins were found to be significantly õ32 kDa. The differ- first validated on 14 PBMC samples in which nef quasispecies Lanes 1 -4 in figure 2 show the TT results of uncloned nef sequences. PCR product from samples IC763006 (lane 1) and were previously characterized by TT analysis of nef clones. A comparison of representative TT results from cloned and S173 (lane 2) showed a mixture of truncated (24-kDa) and full-length (34-kDa) Nef proteins, and samples IC763017 (lane uncloned nef genes from the same samples are shown in figures 1 and 2, respectively. In figure 1 , lanes 1 -9 are from subject 3) and IC03689 (lane 4) showed only full-length (34-kDa) or truncated (õ14-kDa) Nef proteins, respectively. Concordant IC763006, showing a mixture of full-length (34-kDa) and truncated (24-kDa) Nef clones, lanes 13 -21 are from subject TT results were observed between the two methods, suggesting that direct screening by TT analysis of uncloned nef products IC763017, with only full-length Nef proteins, and lanes 22 -30 are from subject IC03689, with only truncated Nef proteins.
is equivalent to screening of cloned products. Therefore, this assay is a reliable alternative to TT analysis of cloned nef genes Low-molecular-mass proteins (õ16 kDa) were commonly observed traveling with the dye front ( figure 1, lanes 1 -12 and and has the advantages of being rapid and less labor-intensive. Additional samples identified by this method as having only 22 -30) and may represent labeled proteins that are translated from nonspecific internal initiation sites, as previously experitruncated Nef proteins are shown in lanes 7 and 12 of figure 2. These 2 samples are from patients IC763124 and IC763115 enced when using TT analysis [18] . (table  2) , respectively. Lanes 5, 6, [8] [9] [10] [11] [13] [14] [15] [16] [17] [18] and were further subjected to additional TT analysis of cloned frame open but significantly shortened the size of the Nef protein (e.g., samples S1084, IC763115, and IC763006) (figure nef genes and shown to have a majority of truncated Nef proteins (table 2) . The remaining samples in figure 2 represent 3). Analysis of the nef-LTR overlap region showed that both the gross deletions and the hypermutations in the nef defective specimens that were all considered to have full-length Nef proteins.
sequences did not affect the polypurine tract, the NF-kB binding site, or other sequence motifs thought to be important for Mechanism of Nef truncation. To determine the mechanism of protein truncation in the 7 samples with evidence of transcription. truncated Nef, nef clones were sequenced, and the deduced amino acid sequence was analyzed. Two mechanisms of Nef Discussion protein truncation were observed. First, Nef proteins from subjects IC763124, IC763012, and IC762993 were truncated from Because of the overall genetic relatedness of HIV-2 to SIV, and the importance of intact nef genes to the development of the introduction of premature stop codons in the nef ORF as a result of GjA hypermutation ( figure 3 ). The rate of GjA AIDS in SIV infections, the nef gene of HIV-2 was selected in this study as a primary target for analysis as having a possible hypermutation calculated for the region encompassing the nef gene amplified in patient samples IC762993 and IC763124 role in the pathogenesis of this virus [4, 7] . We have examined clones of nef genes from a large number of symptomatic and was 42.8% and 27.3%, respectively. The second cause of Nef truncation, observed in subjects IC03689, S1084, IC763006, asymptomatic HIV-2 infections and screened for nef ORF interruptions by using TT analysis. In addition, we have determined and IC763115, was deletions in the nef gene. The gross deletions either caused frameshift mutations that introduced premaby sequence analysis the mechanism of Nef truncations that were detected in some samples. ture stop codons (e.g., sample IC03689) or kept the nef reading The data show that 10% of HIV-2 infections had predomiration of virulence, the deletions seen in all 4 HIV-2 samples are much larger and may be more difficult to repair [22] . nantly Nef truncations and that there was a trend toward the association of Nef truncation with asymptomatic (13.8%) infecIn summary, the present study provides new evidence on the presence of HIV-2 infections with Nef truncation. The high tion compared with symptomatic infection (4.2%). While the difference in frequency of Nef truncation between symptomatic frequency of this Nef truncation raises important questions regarding the possible role of defective Nef in HIV-2 -infected and asymptomatic subjects was not statistically significant, the data, nevertheless, raise important observations. First, Nef trunpersons with long asymptomatic stages or delayed disease development and, therefore, argues for additional studies of nef cation may be occurring more frequently in HIV-2 infection (10%) than in HIV-1 infection (õ1%). Although the prevalence in these infections. The laboratory tools used here to rapidly screen for Nef truncation may be useful for future studies in of Nef truncation in HIV-1 infections has been studied only in small cohorts and may not allow a good comparison with the this field. findings from this study, the data from these cohorts suggest a low prevalence of HIV-1 Nef truncation in patients with various rates of disease progression [10 -15] . Evidence of HIV-
